Putnam BioRevolution ETF (SYNB)

NYSEARCA: SYNB · Real-Time Price · USD
26.49
+0.49 (1.90%)
Apr 22, 2025, 4:00 PM EDT - Market closed
1.90%
Assets $4.56M
Expense Ratio 0.71%
PE Ratio 27.92
Shares Out 175,000
Dividend (ttm) $0.21
Dividend Yield 0.81%
Ex-Dividend Date Dec 5, 2024
Payout Ratio 22.97%
1-Year Return -8.67%
Volume n/a
Open 26.49
Previous Close 26.00
Day's Range 26.49 - 26.49
52-Week Low 24.57
52-Week High 33.23
Beta 1.00
Holdings 38
Inception Date Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

Asset Class Equity
Category Health
Stock Exchange NYSEARCA
Ticker Symbol SYNB
ETF Provider Putnam

Top 10 Holdings

49.86% of assets
Name Symbol Weight
Thermo Fisher Scientific Inc. TMO 8.39%
AbbVie Inc. ABBV 5.73%
Corteva, Inc. CTVA 5.56%
Bio-Rad Laboratories, Inc. BIO 5.06%
Novonesis A/S NVZMY 4.94%
AstraZeneca PLC AZN 4.42%
Eli Lilly and Company LLY 4.20%
Ascendis Pharma A/S ASND 4.03%
Alphabet Inc. GOOGL 3.79%
NVIDIA Corporation NVDA 3.74%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 5, 2024 $0.2139 Dec 9, 2024
Dec 6, 2023 $0.0211 Dec 11, 2023
Full Dividend History

News

Putnam Investments Launches Fixed Income and Non-U.S. Equity Exchange-Traded Funds

BOSTON--(BUSINESS WIRE)--Putnam Investments today announced that it has officially launched five new transparent, actively managed exchange-traded funds (ETFs) that begin trading today on the New Yo...

2 years ago - Business Wire

Putnam Investments to Launch Two Innovative Active ETFs

BOSTON--(BUSINESS WIRE)--On Friday, September 30, Putnam Investments will begin to offer two new transparent, actively managed, equity exchange-traded funds (ETFs). The firm will be launching Putnam B...

Other symbols: PBDC
2 years ago - Business Wire